Ceruloplasmin, hephaestin and zyklopen: The three multicopper oxidases important for human iron metabolism;Ceruloplazmina, hefajstyna i cyklopen: Trzy multimiedziowe oksydazy uczestniczące w metabolizmie zelaza u czlowieka

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 68, Issue , 2014, Pages 912-924

  Wierzbicka, Diana ^a   Gromadzka, Grazyna ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Ceruloplasmin; Hephaestin; Iron metabolism; Oxidases; Zyklopen

Indexed keywords

APOPROTEIN; APOTRANSFERRIN; CERULOPLASMIN; COPPER OXIDASE; HEPH PROTEIN, HUMAN; IRON; MEMBRANE PROTEIN; OXIDOREDUCTASE; TRANSFERRIN; ZYKLOPEN PROTEIN, HUMAN;

BINDING SITE; FEMALE; HUMAN; INTESTINE MUCOSA; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; PLACENTA; PREGNANCY; TRANSPORT AT THE CELLULAR LEVEL;

APOPROTEINS; BINDING SITES; BIOLOGICAL TRANSPORT; CERULOPLASMIN; FEMALE; HUMANS; INTESTINAL MUCOSA; IRON; MEMBRANE PROTEINS; OXIDATION-REDUCTION; OXIDOREDUCTASES; PLACENTA; PREGNANCY; TRANSFERRIN;

EID: 84920577188     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1111136     Document Type: Review

References (95)

1. Abdou M., Shaban H., Gohary M.: Changes in serum zinc, cop-per and ceruloplasmin levels of whole body gamma irradiated rats. Tenth Radiation Physics & Protection Conference. 27-30 November, Nasr City - Cairo, Egypt- Conference Proceedings, 2010; 17-26
2. Amaravadi R., Glerum D.M., Tzagoloff A.: Isolation of a cDNA encoding the human homolog of COX17, a yeast gene essential for mitochondrial copper recruitment. Hum. Genet., 1997; 99: 329-333
3. Anderson C.P., Shen M., Eisenstein R.S., Leibold E.A.: Mammalian iron metabolism and its control by iron regulatory proteins. Biochim. Biophys. Acta, 2012; 1823: 1468-1483
4. Anderson G.J., Frazer D., McKie A., Vulpe C.: The ceruloplasmin homolog hephaestin and the control of intestinal iron asorption. Blood Cells Mol. Dis., 2002; 29: 367-375
5. Andrews N.: Forging a field: The golden age of iron biology. Blo-od, 2008; 112: 219-230
6. Angelova M., Asenova S., Nedkova V., Kolarova-Koleva R.: Copper in the human organism. TJS, 2011; 9: 88-98
7. Arredondo M., Martines R., Nunez M., Ruz M., Olivares M.: In-hibition of iron and copper uptake by iron, copper and zinc. Biol. Res., 2006; 39: 95-102
8. Banha J., Marques L., Oliveira R., Martins M., Paixao E., Pereira D., Malho R., Penque D., Costa L.: Ceruloplasmin expression by human peripheral blood lymphocytes: A new link between immunity and iron metabolism. Free Radic. Biol. Med., 2008; 44: 483-492
9. Bartee M.Y., Lutsenko S.: Hepatic copper-transporting ATPase ATP7B: Function and inactivation at the molecular and cellular level. Biometals, 2007; 20: 627-637
10. Bento I., Peixoto C., Zaitsev V.N., Lindley P.F.: Ceruloplasmin revisited: Structural and functional roles of various metal cation- binding sites. Acta Crystallogr. D Biol. Crystallogr., 2007; 63: 240-248
11. Bielli P., Calabrese L.: Structure to function relationships in ceruloplasmin: A 'moonlighting' protein. Cell. Mol. Life Sci., 2002; 59: 1413-1427
12. Brewer G.J.: Iron and copper toxicity in diseases of aging, par-ticularly atherosclerosis and Alzheimer's disease. Exp. Biol. Med., 2007; 232: 323-335
13. Brookes M.J., Hughes S., Turner F.E., Reynolds G., Sharma N., Ismail T., Berx G., McKie A.T., Hotchin N., Anderson G.J., Iqbal T., Tselepis C.: Modulation of iron transport proteins in human colo-rectal carcinogenesis. Gut, 2006; 55: 1449-1460
14. Buffone G.J., Brett E.M., Lewis S.A., Iosefsohn M., Hicks J.M.: Li-mitations of immunochemical measurement of ceruloplasmin. Clin. Chem., 1979; 25: 749-751
15. Chen H., Attieh Z.K., Dang T., Huang G., Van Der Hee R.M., Vulpe C.: Decreased hephaestin expression and activity leads to decreased iron efflux from differentiated Caco2 cells. J. Cell. Biochem., 2009; 107: 803-808
16. Chen H., Attieh Z.K., Syed B.A., Kuo Y.M., Stevens V., Fuqua B.K., An-dersen H.S., Naylor C.E., Evans W.R., Gambling L., Danzeisen R., Haidar M.B., Usta J., Vylpe C.D., McArdle H.J.: Identification of zyklopen, a new member of the vertebrate multicopper ferroxidase family, and charac-terization in rodents and human cells. J. Nutr., 2010; 140: 1728-1735
17. Chen H., Huang G., Gao H., Attieh Z., McKie A., Anderson G., Vulpe C.: Decreased hephaestn activity in the intestine of copper-deficient mice causes systematic iron deficiency. J. Nutr., 2006; 136: 1236-1241
18. Chen H., Su T., Attieh Z., Fox T., McKie A., Anderson G., Vulpe C.: Systematic regulation of hephaestin and Ireg1 revealed in studies of genetic and nutritional iron deficiency. Blood, 2013; 102: 1893-1899
19. Church W.R., Jernigan R.L., Tolle J., Hewick R.M., Knopf J., Knut-son G.J., Nesheim M.E., Mann K.G., Fass D.N.: Coagulation factors V and VIII and ceruloplasmin constitute a family of structurally related proteins. Proc. Natl. Acad. Sci. USA, 1984; 81: 6934-6937
20. Cui R., Duan X.L., Anderson G.J., Qiao Y.P., Yu P., Qian Z.N., Yoshi-da K., Takeda S., Guo P., Yang Z.L., Chang Y.Z.: Age-dependent expres-sion of hephaestin in the brain of ceruloplasmin-deficient mice. J. Trace Elem. Med. Biol., 2009; 23: 290-299
21. Culotta V.C., Klomp L.W,. Strain J., Casareno R.L., Krems B., Gitlin J.D.: The copper chaperone for superoxide dismutase. J. Biol. Chem., 1997; 272: 23469-23472
22. Czlonkowska A., Gromadzka G., Szpak G.M., Chabik G.: Choroba Wilsona, Choroba Parkinsona i inne zaburzenia, t.2, red: Slawek J., Friedman A., Bogucki A., Opali G. Via Medica, Gdańsk 2012, 403-420
23. Dameron C.T., Harrison M.D.: Mechanisms for protection against copper toxicity. Am. J. Clin. Nutr., 1998; 67 (5 Suppl.): 1091S-1097S
24. de Bie P., van de Sluis B., Klomp L., Wijmenga C.: The many fa-ces of the copper metabolism protein MURR1/COMMD1. J. Hered., 2005; 96: 803-811
25. Dusek P., Jankovic J., Le W.: Iron dysregulation in movement disorders. Neurobiol. Dis., 2012; 46: 1-18
26. Flora S.J., Mittal M., Mehta A.: Heavy metal induced oxidative stress & its possible reversal by chelation therapy. Indian J. Med. Res., 2008; 128: 501-523
27. Friedan E.: Ceruloplasmin: A multi- functional cupro- protein of vertebrate plasma. Exp. Biol. Med., 1982; 2: 159-169
28. Gaetke L.M., Chow C.K.: Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology, 2003; 189: 147-163
29. Ganz T.: Hepcidin, a key regulator of iron metabolism and me-diator of anemia of inflammation. Blood, 2003; 102: 783-788
30. Garrick M.D., Golan K.G., Horbinski C., Ghio A.J., Higgins D., Po-rubcin M., Moore E.G., Hainsworth L.N., Umbreit J.N., Conrad M.E., Feng L., Lis A., Roth J., Singleton S., Garrick L.M.: DMT1: A mammalian transporter for multiple metals. Biometals, 2003; 16: 41-54
31. Gicquel V., Soriano N., Ferran H., Wojcik F., Palierne E., Tamim S., Jovelin T., McKie A., Gall J., David V., Mosser J.: Identification of 96 single nucleotide polymorphisms in eight genes involved in iron metabolism: Efficiency of bioinformatic extraction compared with a systematic sequencing approach.. Hum. Genet., 2001; 109: 393-401
32. Graf W.D., Noetzel M.J.: Radical reactions from missing cerulo-plasmin. The importance of a ferroxidase as a endogous antioxidant. Neurology, 1999; 53: 446-447
33. Hahn P., Qian Y., Dentchew T., Chen L., Beard J., Harris Z.L., Du-naief J.L.: Disruption of ceruloplasmin and hephaestin in mice cau-ses retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc. Natl. Acad. Sci. USA, 2004; 101: 13850-13855
34. Hahn P., Ying G., Beard J., Dunaief J.: Iron levels in human re-tina: Sex difference and increase with age. Neuroreport, 2006; 17: 1803-1806
35. Harris L., Davis-Kaplan S., Gitlin J., Kaplan J.: A fungal multi-copper oxidase restores iron homeostasis in aceruloplasminemia. Blood, 2004; 103: 4672-4673
36. Hasan H.R., Ghadhban J.M., Abudal Kadhum Z.I.: Salivary ceru-loplasmin ferroxidase & oxidase activities in celiac patients. Int. J. Biomed. Sci., 2012; 8: 163-170
37. He X., Hahn P., Iacovelli J., Wong R., King C., Bhisitkul R., Massa-ro-Giordano M., Dunaief J.L.: Iron homesostasis and toxicity in retinal degeneration. Prog. Retin Eye Res., 2007; 26: 649-673
38. Hellman N.E., Kono S., Miyajima H., Gitlin J.D.: Biochemical ana-lysis of missense mutation in aceruloplasminemia. J. Biol. Chem., 2002; 277: 1375-1380
39. Holmberg C.G., Laurel C.B.: Investigations in serum copper. Acta Chem. Scand., 1948; 2: 550-556
40. Hudson D., Curtis S., Smith V., Griffiths T., Wong A., Scudamo-re C., Buchan A., MacGillivray T.: Human hephaestin expression is not limited to enterocytes of the gastrointestinal tract but is also found in the antrum, the enteric nervous system, and pancreatic β cells. Am. J. Physiol. Gastrintest. Liver Physiol., 2010; 298: 425-432
41. Jacob R.A., Skala J.H., Omaye S.T., Turnlund J.R.: Effect of vary-ing ascorbic acid intakes on copper absorption and ceruloplasmin levels of young men. J. Nutr., 1987; 117: 2109-2115
42. Jeong S.Y., Dvaid S.: Glycosylophopsphatidylinositol- Achored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem., 2003; 278: 27144-27148
43. Klomp L.W., Lin S.J., Yuan D.S., Klausner R.D., Culotta V.C., Gi-tlin J.D.: Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis. J. Biol. Chem., 1997; 272: 9221-9226
44. Kochanowska I., Hampel-Osipowicz E., Waloszczyk P.: Choroba Menkesa - genetyczny defekt metabolizmu miedzi. Neurol. Dziec., 2008; 17: 63-68
45. Kristinsson J, Snaedal J, Tórsdóttir G, Jóhannesson T.: Cerulopla-smin and iron in Alzheimer's disease and Parkinson's disease: A sy-nopsis of recent studies. Neuropsychiatr. Dis. Treat., 2012; 8: 515-521
46. Kuo Y.M., Su T., Chen H., Attieh Z., Syed B.A., McKie A.T., An-derson G.J., Gitschier J., Vulpe C.D.: Mislocalisation of hephaestin, a multicopper ferroxidase involved in basolateral intestinal iron transport, in the sex linked anaemia mouse. Gut, 2004; 53: 201-206
47. Lee D.A., Goodfellow J.M.: The p-H induced release of iron from transferrin investigated with cintinuum electrostatic model. Bio-phys. J., 1998; 74: 2747-2759
48. Lee S.M., Attieh Z.K., Son H.S., Chen H., Bacouri-Haidar M., Vulpe C.D.: Iron repletion relocalizes hephaestin to a proximal basolateral compartment in polarized MDCK and Caco2 cells. Biochem. Biophys. Res. Commun., 2012; 421: 449-455
49. Li Y., Bai B., Cao X., Yan H., Zhuang G.: Ferroportin 1 and hepha-estin expression in BeWo cell line with different iron treatment. Cell. Biochem. Funct., 2012; 30: 249-255
50. Linder M.C., Hazegh-Azam M.: Copper biochemistry and mole-cular biology. Am. J. Clin. Nutr., 1996; 63: 797S-811S
51. Machonkin T.E., Zhang H.H., Hedman B., Hodgson K.O., Solomon E.I.: Spectroscopic and magnetic studies of human ceruloplasmin: Identification of a redox-inactive reduced type 1 copper site. Bio-chemistry, 1998; 37: 9570-9578
52. Maltais D., Desroches D., Aouffen M., Mateescu M.A., Wang R., Paquin J.: The blue copper ceruloplasmin induces aggregation of newly differentiated neurons: A potential modulator of nervous system organization. Neuroscience, 2013; 121: 73-82
53. Merle U., Tuma S., Herrmann T., Muntean V., Volkmann M., Gehrke S.G., Stremmel W.: Evidence for a critical role of cerulopla-smin oxidase activity in iron metabolism of Wilson disease gene knockout mice. J. Gastroenterol. Hepatol., 2010; 25: 1144-1150
54. Mordak-Domagala M., Kuliszkiewicz-Janus M.: Angiogenesis in multiple myeloma - clinical implications., Acta Haematol. Pol., 2007; 38: 177-186
55. Morgan E.H., Oates P.S.: Mechanisms and regulation of intestinal iron absorption. Blood Cells Mol. Dis., 2002; 29: 384-399
56. Morris C.J., Earl J.R., Trenam C.W., Blake D.R.: Reactive oxygen species and iron - A dangerous partnership in inflammation. Int. J. Biochem. Cell Biol., 1995; 27: 109-122
57. Mukhopadhyay C.K., Mazumder B., Fox P.L.: Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J. Biol. Chem., 2000; 275: 21048-21054
58. Mukhopadhyay C.K., Mazumder B., Lindley P.F., Fox P.L.: Identi-fication of the prooxidant site of human ceruloplasmin: A model for oxidative damage by copper bound to protein surfaces. Proc. Natl. Acad. Sci. USA, 1997; 94: 11546-11551
59. Mzhel'skaya T.I.: Biological functions of ceruloplasmin and their deficiency caused by mutation in genes regulating copper and iron metabolism. Bull. Exp. Biol. Med., 2000; 130: 719-727
60. Nittis T., Gitlin J.: Role of copper in proteasome-mediated de-gradation of the multicopper oxidase hephaestin. J. Biol. Chem., 2004; 279: 25696-25702
61. Oide T., Yoshida K., Kaneko K., Ohta M., Arima K.: Iron overload and antioxidative role of perivascular astrocytes in aceruloplasmi-nemia. Neuropathol. Appl. Neurobiol., 2006; 32: 170-176
62. Papanikolau G., Pantopoulos K.: Iron metabolism and toxicity. Toxicol. Appl. Pharmacol., 2005; 202: 199-211
63. Patel B.N., Dunn R.J., Jeong S.Y., Zhu Q., Julien J.P., David S.: Ceru-loplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurousci., 2002; 22: 6578-6586
64. Patel M., Ramavataram D.V.: Non transferris bound iron: Nature, manifestations and analytical approaches for estimation. Indian J. Clin. Biochem., 2012; 27: 322-332
65. Petrak J., Vyoral D.: Hephaestin - A ferroxidase of cellular iron export. Inst. J. Biochem. Cell Biol., 2005; 37: 1173-1178
66. Pribyl T.: Serum polyphenol oxidase activity (ceruloplasmin) in conventional laboratory animals and man. Folia Biol., 1978; 24: 136-141
67. Prohaska J.R.: Impact of copper deficiency in humans. Ann. N.Y. Acad. Sci., 2014; 1314: 1-5
68. Prohaska J.R.: Impact of copper limitation on expression and function of multicopper oxidases (ferroxidases). Adv. Nutr., 2011; 2: 89-95
69. Qian M.Z., Chang Z.Y., Leung G., Du R.J., Zhu L., Wang Q., Niu L., Xu Y.J., Yang L., Ho K.P., Ke Y.: Expression of ferroportin hepha-estin and ceruloplasmin in rat heart. Biochim. Biophys Acta, 2007; 1772: 527-532
70. Qian Z.M., Shen X.: Brain iron transport and neurodegenration. Trends Mol. Med., 2001; 7: 103-108
71. Quintanar L., Gebhard M., Wang T.P., Kosman D.J., Solomon E.I.: Ferrous binding to themulticopper oxidases Saccharomyces cerevisiae Fet3p and human ceruloplasmin: Contributions to ferroxidase acti-vity. J. Am. Chem. Soc., 2004; 126: 6579-6589
72. Ranganathan P.N., Lu Y., Fuqua B.K., Collins F.J.: Immunoreacti-ve hephaestin and ferroxidase acticity are present in the cytosolic fraction of rat enterocytes. Biometals, 2012; 25: 687-695
73. Roeser H.P., Lee G.R., Nacht S., Cartwright G.E.: The role of ce-ruloplasmin in iron metabolism. J. Clin. Invest., 1970; 49: 2408-2417
74. Salih A.M.: Serum ceruloplasmin, copper and iron levels as a risk factors for coronary heart diseases (CHD). Bahdad Sci. J., 2010; 7: 372-381
75. Sedlak E., Wittung- Stafshede P.: Discrete roles of copper ions in chemical unfolding of human ceruloplasmin. Biochemistry, 2007; 46: 9638-9644
76. Sharp P.: The molecular basis of copper and iron metabolism. Proc. Nutr. Soc., 2004; 63: 563-569
77. Shokeir M.H., Shreffler D.C.: Cytochrome oxidase deficiency in Wilson's disease: A suggested ceruloplasmin function. Proc. Natl. Acad. Sci. USA, 1969; 62: 867-872
78. Song D., Dunaief J.L.: Retinal iron homeostasis in health and disease. Front Aging Neurosci., 2013; 5: 24
79. Song N., Wang J., Jiang H., Xie J.: Ferroportin 1 but not hepha-estin contributes to iron accumulation in a cell model of Parkinson's disease. Free Radic. Biol. Med., 2010; 48: 332-341
80. Stern B.R., Solioz M., Krewski D., Aggett P., Aw T.C., Baker S., Crump K., Dourson M., Haber L., Hertzberg R., Keen C., Meek B., Ru-denko L., Schoeny R., Slob W., Starr T.: Copper and human health: Biochemistry, genetics and strategies for modeling dose-response relationships. J. Toxicol. Environ. Health, 2007; 10: 157-222
81. Suzuki Y., Yoshida K., Aburakawa Y., Kuroda K., Kimura T., Terada T., Kono S., Miyajima H., Yahara O.: Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation. Intern. Med., 2013; 52: 1527-1530
82. Syed B., Beamount J., Patel A., Naylor C., Bayele H., Joannou C., Rowe P., Evans R., Srai K.: Analysis of the human hephaestin gene and protein: Comparative modeling of the N-terminus ecto- domein based upon ceruloplasmin. Protein Eng., 2002; 15: 205-214
83. Tapryal N., Mukhopadhyay C., Das D., Fox P.L., Mukhopadhy-ay C.K.: Reactive oxygen species regulate ceruloplasmin by a novel mRNA decay mechanism involving its 3'-untranslated region: Im-plications in neurodegenerative diseases. J. Biol. Chem., 2009; 284: 1873-1883
84. Terada K., Schilsky M.L., Miura N., Sugiyama T.: ATP7B (WND) protein. Int. J. Biochem. Cell Biol., 1998; 30: 1063-1067
85. Texel S., Zhang J., Camandola S., Unger E., Taub D., Koehler R., Harris Z., Mattson M.: Ceruloplasmin deficiency reduces levels of iron and BNDF in the cortex and striatum of young mice and incre-ases their vulnerability to stroke. PLoS One, 2011; 6: E25077
86. Umbreit J.: Iron deficiency: A concise review. J. Hematol., 2005; 78: 225-231
87. Vaschenko G., Bleackley M., Grifiths T., MacGillivray R.: Oxi-dation of organic and biogenic amines by recombinant human he-phaestin expressed in Pichia pastoris. Arch. Biochem. Biophys., 2011; 514: 50-56
88. Vaschenko G., Ross T., MacGillivray A.: Multi-copper oxidases and human iron metabolism. Nutrients, 2013; 5: 2289-2313
89. Vassiliev V., Harris Z.L., Zatta P.: Ceruloplasmin in neurodegene-rative diseases. Brain Res. Brain Res. Rev., 2005; 49: 633-640
90. Verma V.K., Ramesh V., Tewari S., Gupta R.K., Sinha N., Pan-dey C.M.: Role of bilirubin, vitamin C and ceruloplasmin as antio-xidants in coronary artery disease [CAD]. Indian J. Clin. Biochem., 2005; 20: 68-74
91. Wang J., Pantopolous K.: Regulation of cellular iron metabolism. Biochem. J., 2011; 434: 365-381
92. Yamaguchi Y., Aoki T., Asashima S., Ooura T., Takada G., Kita-gawa T., Shigematsu Y., Shimada M., Kobayashi M., Itou M., Endo F.: Mass screening for Wilson's disease: Results and recommendations. Pediatr. Int., 1999; 41: 405-408
93. Yamamoto K., Yoshida K., Miyagoe Y., Ishikawa A., Hanaoka K., Nomoto S., Kaneko K., Ikeda S., Takeda S.: Quantitative evaluation of expression of iron-metabolism genes in ceruloplasmin-deficient mice. Biochim. Biophys. Acta, 2002; 1588: 195-202
94. Young S.N., Curzon G.: A method for obtaining linear recipro-cal plots with caeruloplasmin and its application in a study of the kinetic parameters of caeruloplasmin substrates. Biochem. J., 1972; 129: 273-283
95. Zaitsev V.N., Zaitseva I., Papiz M., Lindley P.F.: An X-ray cry-stallographic study of the binding sites of the azide inhibitor and organic substrates to ceruloplasmin, a multi-copper oxidase in the plasma. J. Biol. Inorg. Chem., 1999; 4: 579-587